Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Schultz

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 19, 2006
Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinomaDian Wang, Christopher J Schultz, Paul A Jursinic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Early postoperative paclitaxel followed by concurrent paclitaxel and cisplatin with radiation therapy for patients with resected high-risk head and neck squamous cell carcinoma: report of the phase II trial RTOG 0024David I Rosenthal, Jonathan Harris, Arlene A Forastiere, et al.
Advances in Radiation Oncology|May 8, 2023
Assessment of Differences in Academic Rank and Compensation by Gender and Race/Ethnicity Among Academic Radiation Oncologists in the United StatesAnn C Raldow, Malika L Siker, James A Bonner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2016
Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227Jon Glass, Minhee Won, Christopher J Schultz, et al.
Frontiers in Oncology|December 23, 2022
Case report: Fractional brain tumor burden magnetic resonance mapping to assess response to pulsed low-dose-rate radiotherapy in newly-diagnosed glioblastomaRyan F Amidon, Fernando Santos-Pinheiro, Michael Straza, et al.
International Journal of Radiation Oncology, Biology, Physics|November 28, 2012
RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patientsArnab Chakravarti, Meihua Wang, H Ian Robins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2002
Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end pointsMinesh P Mehta, William R Shapiro, Michael J Glantz, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 13, 2019
Salvage of Recurrence after Surgery and Adjuvant Therapy: A Multi-institutional StudyJoseph Zenga, Evan Graboyes, Tyler Janz, et al.
International Journal of Radiation Oncology, Biology, Physics|October 2, 2017
Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine ConferenceWilliam A Hall, Carmen Bergom, Reid F Thompson, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2012
Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neckJay S Cooper, Qiang Zhang, Thomas F Pajak, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
International Journal of Radiation Oncology, Biology, Physics|April 19, 2006
Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinomaDian Wang, Christopher J Schultz, Paul A Jursinic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Early postoperative paclitaxel followed by concurrent paclitaxel and cisplatin with radiation therapy for patients with resected high-risk head and neck squamous cell carcinoma: report of the phase II trial RTOG 0024David I Rosenthal, Jonathan Harris, Arlene A Forastiere, et al.
Advances in Radiation Oncology|May 8, 2023
Assessment of Differences in Academic Rank and Compensation by Gender and Race/Ethnicity Among Academic Radiation Oncologists in the United StatesAnn C Raldow, Malika L Siker, James A Bonner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2016
Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227Jon Glass, Minhee Won, Christopher J Schultz, et al.
Frontiers in Oncology|December 23, 2022
Case report: Fractional brain tumor burden magnetic resonance mapping to assess response to pulsed low-dose-rate radiotherapy in newly-diagnosed glioblastomaRyan F Amidon, Fernando Santos-Pinheiro, Michael Straza, et al.
International Journal of Radiation Oncology, Biology, Physics|November 28, 2012
RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patientsArnab Chakravarti, Meihua Wang, H Ian Robins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2002
Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end pointsMinesh P Mehta, William R Shapiro, Michael J Glantz, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 13, 2019
Salvage of Recurrence after Surgery and Adjuvant Therapy: A Multi-institutional StudyJoseph Zenga, Evan Graboyes, Tyler Janz, et al.
International Journal of Radiation Oncology, Biology, Physics|October 2, 2017
Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine ConferenceWilliam A Hall, Carmen Bergom, Reid F Thompson, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2012
Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neckJay S Cooper, Qiang Zhang, Thomas F Pajak, et al.
Pageof 7